Trials / Completed
CompletedNCT02958514
Efficacy Comparison of Two Kinds of Treatment in Treating Dry Eye Caused by Meibomian Gland Dysfunction
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 26 Years – 78 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the efficacy of intense pulsed light in treating dry eye caused by meibomian gland dysfunction and make a comparison between the traditional treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | intense pulsed light | Intense pulse light (IPL) has been used in dermatology practices for several years as a treatment for rosacea and acne.IPL uses Xenon flashlamp to emit wavelengths of light from 400 to 1200nm. When placed on the light, a filter restricts the wavelength to the visible light range of \*500nm.In 2007-2008, an IPL treatment technology-the Diamond Q4 by DermaMed Solutions-was specifically configured to our specifications with the goal of stimulating secretion of normal meibum via skin treatment effects on the meibomian glands. It was discovered that dry eye patients are better positioned for gland expression, as IPL seems to liquefy the abnormal viscous meibum and dilate the glands. |
| DRUG | Tobramycin and Dexamethasone Ophthalmic Ointment |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2017-02-01
- Completion
- 2017-03-01
- First posted
- 2016-11-08
- Last updated
- 2022-05-05
Source: ClinicalTrials.gov record NCT02958514. Inclusion in this directory is not an endorsement.